The article presents a study on a possible new approach to improving wound healing in aging skin. Researchers from Boston University investigated ABT-263, an experimental senolytic treatment designed to eliminate senescent cells. These cells are damaged or stressed cells that stop dividing but remain in the body. As they accumulate with age, they can contribute to inflammation and interfere with normal tissue repair. Therefore, the researchers explored whether removing some of these cells from aging skin could improve its ability to recover after an injury.
To investigate this possibility, the researchers applied ABT-263 directly to the skin of older mice for five days. After the treatment, they created small wounds and monitored the healing process. By the 24th day, 80% of the treated mice had completely healed their wounds, compared with 56% of the untreated mice. These results suggest that reducing the number of senescent cells before an injury may help older skin respond more effectively to the healing process.
Interestingly, the treatment also produced changes related to inflammation and tissue regeneration. Although excessive or prolonged inflammation can interfere with healing, a temporary inflammatory response is an important part of normal wound repair. In this study, ABT-263 temporarily increased inflammatory activity and appeared to activate genes associated with collagen production and new blood vessel formation. Consequently, the treatment may have helped create conditions that allowed damaged tissue to repair itself more efficiently.
Furthermore, the researchers observed that the treatment primarily affected aging skin, where senescent cells are more abundant. Applying the treatment directly to the skin could potentially limit exposure to other parts of the body compared with systemic administration. However, the findings are still preclinical, since the experiments were conducted in mice rather than humans. Additional research is necessary to determine whether ABT-263 is safe and effective for people. Nevertheless, the study contributes to growing research into senolytic therapies and their potential applications in wound care, surgical recovery, and age-related tissue repair.
Link to the article: DOWNLOAD
Reference
- Shvedova, M., Samdavid Thanapaul, R. J. R., Ha, J., Dhillon, J., Shin, G. H., Crouch, J., Gower, A. C., Gritli, S., & Roh, D. S. (2024). Topical ABT-263 treatment reduces aged skin senescence and improves subsequent wound healing. Aging, 17(1), 16. https://doi.org/10.18632/aging.206165